Investing.com2d agobullish
Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugsNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
108last 24h
3128last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Investor's Business Daily2d agobullish
Hims & Hers Surges On 'Surprising And Inevitable' Deal With Eli LillyGuruFocus.com4d agobullish
Novo Nordisk AS (NVO) (Q3 2026) Earnings Call Highlights: Obesity Sales Surge 22% as Wegovy ...MT Newswires4d agobullish
European Stocks Rally in Wednesday Trading Following US Elections; Euro Area Inflation RisesInvestor's Business Daily4d agobullish
Novo Surges 6% After Walloping Expectations On The Back Of Its GLP-1 DrugsInvestor's Business Daily4d agobullish
Novo Surges 5% After Walloping Expectations On The Back Of Its GLP-1 DrugsInvesting.com4d agobullish
European shares gain on Novo’s results; markets weigh U.S. midtermsBarrons.com47d agobullish
Viking Therapeutics Stock Surges 30%. It Could Challenge Lilly and Novo’s Obesity Empire.MarketWatch64d agobullish
Plastic surgery is booming with boomers. Here’s how to cash in on the antiaging craze.Financial Times95d agobullish
Eli Lilly and Novo Nordisk raise profit outlook as demand for weight-loss drugs soars